Literature DB >> 32222825

MAML2 rearrangement as a useful diagnostic marker discriminating between Warthin tumour and Warthin-like mucoepidermoid carcinoma.

Michał Bieńkowski1, Michał Kunc2, Mariola Iliszko3, Alina Kuźniacka3, Michał Studniarek4, Wojciech Biernat2.   

Abstract

Warthin tumour is the second most common benign neoplasm of salivary glands. Despite its relatively characteristic histology, it may sometimes mimic other lesions. Here, we report two female non-smoker patients diagnosed with low-grade mucoepidermoid carcinoma with oncocytic epithelium and prominent lymphoid (Warthin-like) stroma and with molecularly confirmed MAML2 rearrangement. In addition, we screened a consecutive series of 114 Warthin tumour cases by means of MAML2 break apart fluorescence in situ hybridization to assess its value in differential diagnosis. MAML2 rearrangement was detected in both mucoepidermoid carcinoma cases, while all Warthin tumours were negative. Taking into account the literature data, Warthin-like mucoepidermoid carcinomas are more frequently observed in women, while a slight male predominance and smoking history are typical for Warthin tumour. In addition, the patients with Warthin-like mucoepidermoid carcinoma were significantly younger than those with Warthin tumour. To conclude, Warthin-like mucoepidermoid carcinoma may usually be suspected based on histology, while the diagnosis can be confirmed by means of molecular assays such as FISH. The investigation of MAML2 status is particularly advised when Warthin tumour is considered in a young, non-smoking, female patient.

Entities:  

Keywords:  MAML2 rearrangement; T(11;19) translocation; Warthin tumour; Warthin-like mucoepidermoid carcinoma

Year:  2020        PMID: 32222825     DOI: 10.1007/s00428-020-02798-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  3 in total

Review 1.  Current Trends and Controversies in the Management of Warthin Tumor of the Parotid Gland.

Authors:  Miquel Quer; Juan C Hernandez-Prera; Carl E Silver; Maria Casasayas; Ricard Simo; Vincent Vander Poorten; Orlando Guntinas-Lichius; Patrick J Bradley; Wai Tong-Ng; Juan P Rodrigo; Antti A Mäkitie; Alessandra Rinaldo; Luiz P Kowalski; Alvaro Sanabria; Remco de Bree; Robert P Takes; Fernando López; Kerry D Olsen; Ashok R Shaha; Alfio Ferlito
Journal:  Diagnostics (Basel)       Date:  2021-08-13

2.  Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma.

Authors:  Julia C Thierauf; Alex A Farahani; B Iciar Indave; Adam Z Bard; Valerie A White; Cameron R Smith; Hetal Marble; Martin D Hyrcza; John K C Chan; Justin Bishop; Qiuying Shi; Kim Ely; Abbas Agaimy; Maria Martinez-Lage; Vania Nose; Miguel Rivera; Valentina Nardi; Dora Dias-Santagata; Salil Garg; Peter Sadow; Long P Le; William Faquin; Lauren L Ritterhouse; Ian A Cree; A John Iafrate; Jochen K Lennerz
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

3.  Warthin-like mucoepidermoid carcinoma of the parotid gland: a clinicopathological analysis of two cases.

Authors:  Ruixue Lei; Haijun Yang
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.